Latest Market Research Reports

  Prostate Cancer Diagnostics Market Summary The global  prostate cancer diagnostics market  size was estimated at USD 7.72 billion in 2023 and is projected to reach USD 11.90 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030. Market growth is strongly influenced by the rising prevalence of prostate cancer worldwide, which continues to be a major health concern for aging male populations. According to an article by the American Society of Clinical Oncology (ASCO) published in March 2023, prostate cancer remains the most common cancer among men, reflecting its widespread impact and the increasing need for effective diagnostic solutions. About 288,300 men are estimated to be diagnosed with prostate cancer in 2023. Additionally, around 1.41 million people globally were diagnosed with prostate cancer in 2020, making it the fourth most diagnosed cancer across all populations. The expanding global geriatric population, which is more prone to prostate-related health i...

Prostate Cancer Diagnostics Industry Overview The global prostate cancer diagnostics market size was valued at USD 2.83 billion in 2019 and is anticipated to expand at a CAGR of 13.2% during the forecast period. Increasing prevalence of prostate cancer is one of the major factors propelling the demand for diagnostic products. According to the National Cancer Institute, in the U.S., approximately 174,650 new cases were diagnosed in 2019.   Technological advancements in diagnostic tests are expected to further fuel market growth during the forecast period. According to the National Cancer Institute, researchers are currently testing the use of Artificial Intelligence (AI) to diagnose prostate cancer. AI tools are used for identifying suspicious areas seen during a Magnetic Resonance Imaging (MRI) scan that require biopsies to confirm the presence of malignant cells. Artificial intelligence tools are also being tested in order to improve biopsy sample analysis fa...